Ezar Hafez

466 citations
22 papers · 259 indexed · h-index 10
Topics
Chemotherapy-induced organ toxicity mitigation (6 papers)Thyroid Disorders and Treatments (3 papers)Liver Disease Diagnosis and Treatment (2 papers)
Partner nations
EgyptSaudi ArabiaJapan

In The Last Decade

Ezar Hafez

20 papers receiving 247 citations

Peers

Ezar Hafez
Comparison fields: 5 of 72
  • Molecular Biology 54
  • Pathology and Forensic Medicine 45
  • Plant Science 43
  • Pharmacology 38
  • Complementary and alternative medicine 33
Replace Muhammet Bahaeddi̇n Dörtbudak with:
Muhammet Bahaeddi̇n Dörtbudak Türkiye
Roohollah Mohseni Iran
Fangfang Lang China
Azam Rezaei Farimani Iran
Shen Zhang China
Duangporn Werawatganon Thailand
Randa A. Zaghloul Egypt
Farida Hussan Malaysia
Prasong Siriviriyakul Thailand
Hesham A. Khalifa Egypt
Ezar Hafez relative to Muhammet Bahaeddi̇n Dörtbudak Türkiye Muhammet Bahaeddi̇n Dörtbudak's profile →
Citations per field
00.5×10×15×
Muhammet Bahaeddi̇n Dörtbudak · 1×
Citations per year

Countries citing papers authored by Ezar Hafez

Since Specialization
Citations

This map shows the geographic impact of Ezar Hafez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezar Hafez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezar Hafez more than expected).

Fields of papers citing papers by Ezar Hafez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ezar Hafez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezar Hafez. The network helps show where Ezar Hafez may publish in the future.

Co-authorship network of co-authors of Ezar Hafez

This figure shows the co-authorship network connecting the top 25 collaborators of Ezar Hafez. A scholar is included among the top collaborators of Ezar Hafez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ezar Hafez. Ezar Hafez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 10
3 20
4
Protective Role of Ginseng Root Aqueous Extract Administration on Antineoplastic Drug Cisplatin-induced Spleen Oxidative Stress and Injury
1
5 11
6 6
7 0
8 3
9 9
10 0
11 6
12 3
13
Beneficial role of Panax ginseng root aqueous extract against Cisplatin induced blood toxicity in rats
14
14 3
15 26
16 10
17 57
18 5
19 10
20 2

About Ezar Hafez

Ezar Hafez is a scholar working on Developmental Biology, Molecular Medicine and Complementary and alternative medicine, having authored 22 papers that have together received 259 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (6 papers), Thyroid Disorders and Treatments (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Molecular Medicine (30 citations), Pharmacology (38 citations) and Complementary and alternative medicine (33 citations). Ezar Hafez has collaborated with scholars based in Egypt, Saudi Arabia and Japan. Frequent co-authors include Ehab Tousson, Tamer A. Addissouky, Rehab M. Elgharabawy, Mona Hegazy, Elsayed I. Salim, Magdy E. Mahfouz, Nemany A. N. Hanafy, Stefano Leporatti, Keisuke Izumi and Makoto Sato. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026